| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.035 | 0.2 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.058 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |